Superbugs, Emerging Pathogens and the Evolution of Clinical Genomics
Clinical Genomics is an emerging field of study that uses the power of 'high-throughput' DNA sequencing to address critical public health research questions.
As part of its goal to improve clinical testing and research capacity, PHO has invested in ‘next-generation’ sequencing technology and the development of a DNA Core Facility. This seminar will provide an introduction to Clinical Genomics and review how DNA sequencing activities at the Public Health Laboratories enhance disease surveillance, provide insight into microbial evolution, augment clinical testing, and assist the study of emerging, antibiotic-resistant pathogens.
Presenter: David C. Alexander, PhD
David obtained his PhD in Microbiology and Immunology from McGill University. During his post-doctoral training at the University of Toronto and McGill, he studied diverse aspects of mycobacteriology, including mechanisms of virulence, antibiotic resistance and comparative genomics. David joined the Public Health Laboratories in 2007 and has helped implement molecular tools for universal genotyping of tuberculosis in Ontario. He is currently based in the new PHO DNA Core Facility and is developing tools for clinical genomics.